Upstream Bio, Inc. (UPB) stock news · rev $2.9M
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
This UPB news page leads with what Upstream Bio, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for UPB yet. We will not pad this page with generic market recap.
Latest reported UPB revenue for 2025-12-31 was $2.9M. Net income was -$143.4M. Revenue was up 20.4% from 2024-12-31 to 2025-12-31. UPB currently screens at market cap $407.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the UPB stock page; for the tape open the quote page.
UPB stock news FAQ
What are UPB's latest revenue and net income?
Latest cached Upstream Bio, Inc. (UPB) revenue for Dec 31, 2025 was $2.9M. Net income was -$143.4M. Statements: https://lician.com/financials/upb
How did UPB revenue change from the prior cached period?
Cached Upstream Bio, Inc. (UPB) revenue was up 20.4% from $2.4M (Dec 31, 2024) to $2.9M (Dec 31, 2025). Statements: https://lician.com/financials/upb
What is UPB's market cap?
Upstream Bio, Inc. (UPB) market cap is $407.3M on the latest cached fundamentals snapshot.
What kind of company is UPB?
Upstream Bio, Inc. (UPB) is a biotechnology company listed on US.
Where is UPB stock news listed?
Cached stock news for Upstream Bio, Inc. (UPB) is listed at https://lician.com/news/upb. Filings: https://lician.com/sec/upb
Not investment advice.